Pasqualini T, Zantleifer D, Balzaretti M, Granillo E, Fainstein-Day P, Ramirez J, Ruiz S, Gutman R, Ferraris J
Departamento de Pediatria, Hospital Italiano de Buenos Aires, Argentina.
J Pediatr. 1991 Jun;118(6):873-8. doi: 10.1016/s0022-3476(05)82197-3.
Patients with end-stage renal disease may have abnormalities of growth and of gonadal and thyroid hormones, so we attempted to determine the mechanisms that may be involved in the altered thyroid function. We evaluated serum thyroid hormone levels, their changes immediately after hemodialysis, the serum thyrotropin (thyroid-stimulating hormone (TSH) response to thyrotropin releasing hormone, and the circadian pattern of serum TSH in nine children with end-stage renal disease who were between 7 1/2 years and 17 years 1 month of age. Seven patients had been receiving hemodialysis for a median of 3.3 years; the other two were receiving continuous ambulatory peritoneal dialysis. Four patients had low serum total thyroxine (T4) values, and all nine had low free T4 values. Mean concentrations of total T4, free T4, and total triiodothyronine (T3), which were significantly less than normal before hemodialysis, returned to normal levels immediately after dialysis. Postdialysis thyroid hormone increases did not correlate with the decrease in weight or the increase in hematocrit observed immediately after dialysis. All but one patient had basal TSH levels within the normal range. Three patients had a deficient TSH response to thyrotropin releasing hormone, and the TSH response was prolonged in all of them. The mean (+/- SD) nocturnal TSH surge was 50 +/- 68%. Five of the eight patients studied had a nocturnal TSH surge below the normal range (95% confidence limits 47% to 300%). Serum free T4 values correlated with the TSH nocturnal surge (r, 0.73; p less than 0.05). Our findings support the hypothesis that some patients with end-stage renal disease have central hypothyroidism.
终末期肾病患者可能存在生长、性腺及甲状腺激素异常,因此我们试图确定可能与甲状腺功能改变有关的机制。我们评估了9名年龄在7.5岁至17岁1个月之间的终末期肾病儿童的血清甲状腺激素水平、血液透析后其即刻变化、血清促甲状腺激素(促甲状腺素,TSH)对促甲状腺素释放激素的反应以及血清TSH的昼夜模式。7名患者接受血液透析的中位时间为3.3年;另外两名患者接受持续性非卧床腹膜透析。4名患者血清总甲状腺素(T4)值较低,所有9名患者游离T4值均较低。血液透析前,总T4、游离T4和总三碘甲状腺原氨酸(T3)的平均浓度显著低于正常水平,透析后即刻恢复至正常水平。透析后甲状腺激素升高与透析后即刻观察到的体重减轻或血细胞比容增加无关。除1名患者外,所有患者的基础TSH水平均在正常范围内。3名患者对促甲状腺素释放激素的TSH反应不足,且所有患者的TSH反应均延长。平均(±标准差)夜间TSH峰值为50±68%。在研究的8名患者中,有5名患者的夜间TSH峰值低于正常范围(95%置信区间为47%至300%)。血清游离T4值与TSH夜间峰值相关(r = 0.73;p<0.05)。我们的研究结果支持这样的假设,即一些终末期肾病患者存在中枢性甲状腺功能减退。